Marijuana: A new risk factor for heart disease

April 25, 2024
In a recent study, the risk of stroke rose 42% and the risk of heart attack rose 25% with the daily use of cannabis. In Medical History Mysteries, we unpack what this means for your patients and practice.

When we think of the risk factors for heart disease, we think of obesity, poor diet, lack of exercise, smoking, periodontal disease … but now there’s a new risk: marijuana. More and more evidence points to heart disease and other chronic conditions being associated with the use of cannabis.

A recent study published in the Journal of the American Heart Association links smoking, vaping, and marijuana consumption to a significantly higher risk of heart attack and stroke—even if the user had no existing heart conditions or did not previously smoke or vape tobacco. While both daily and nondaily use of cannabis was associated with an increased risk of heart attack and stroke, the risk of stroke rose 42% and the risk of heart attack rose 25% with daily use of cannabis.

Join us in this episode of Medical History Mysteries as we take a behind-the-scenes look at cannabis and its effects, and why they matter to the dental professional.

Thumbnail background image credit: Jacob Wackerhausen / iStock / Getty Images Plus

More Medical History Mysteries videos …


The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory.

Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.

About the Author

Pamela Maragliano-Muniz, DMD

Pamela Maragliano-Muniz, DMD, is the chief editor of DentistryIQ and editorial co-director of Through the Loupes. Based in Salem, Massachusetts, Dr. Maragliano-Muniz began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano-Muniz owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].

Related:

Pamela Maragliano-Muniz, DMD, named chief editor of DentistryIQ

About the Author

Tom Viola, RPh, CCP

With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.

Updated February 10, 2022